Ultrasound detects AMD differences

Article

Wavelet augmented ultrasound effectively detects differences in choroidal microarchitecture in eyes with wet and dry AMD, according to a recent paper.

Wavelet augmented ultrasound effectively detects differences in choroidal microarchitecture in eyes with wet and dry AMD, according to a recent paper.

The prospective case series headed by Dr D. Jackson Coleman, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Medical Centre, New York, USA, included 69 eyes of 52 patients. The signal from the retina and choroid was extracted via digitized 20 MHz B-scan radiofrequency ultrasound data.

Statistical modelling applied to the wavelet coefficients assessed differences between dry, wet and non-AMD eyes, while receiver operating characteristic (ROC) analysis was adapted to evaluate a multivariate classifier.

The group discovered that 18 patients did not have AMD, 23 had dry AMD and 28 had wet AMD. Multivariate models presented statistically significant differences between groups and multiclass ROC analysis revealed an excellent volume-under-curve of 0.892±0.17.

Ultrasound is highly sensitive to the organizational elements of choroidal microarchitecture with regards to scatter and fluid tissue boundaries as seen in ischaemia and inflammation.

The abstract can be read in the latest online issue of the British Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
Related Content
© 2025 MJH Life Sciences

All rights reserved.